3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

In: Biotechnology News

15 Feb 2010

3SBio Inc, a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis.

Read the original post:
3SBio ties up with Ascentage Pharma to develop & commercialize cancer therapeutics (PharmaBiz)

Comment Form

About Biolexis

Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.

Biotech

    high tech agricultureMicrobiologists icon 3 - Stock illustrationMicrobiologists icon 2 - Stock illustrationMicrobiologists icon 1 - Stock illustrationMicrobiologists icon 4 - Stock illustrationThe Liquid-moving Thingy

Categories

Archives